|
Michele,
I am pretty sure that if you look up the Hera trial on breastcancer.org, there are stats for acx4 then tx4 and Herceptin (by itself after chemo was completed) for a year. I think it was something like 46% reduction in recurrence. Not too bad!
Karen
|